IFNγ blockade resulted in increased frequency of CD45−CD31high tumor endothelial cells (Figure 3K) but did not alter the frequencies of MECA-79+ TA-HECs and bifunctional MECA-79+CD62P+ TA-HECs (Figures 3L and 3M). The gene discussed is IFNG; the disease is neoplasm.